Related Experiment Video
Updated: Apr 27, 2026
Robotic Cochlear Implantation for Direct Cochlear Access
Published on: June 16, 2022
Staphylococcus lugdunensis: Novel Organism causing Cochlear Implant Infection
Samina Bhumbra1, Mona Mahboubi1, R Alexander Blackwood1
1Division of Pediatric Infectious Diseases, University of Michigan , Ann Arbor, MI, USA.
Abstract:
A majority of cochlear implant infections are caused by Staphylococcus aureus or Pseudomonas aeruginosa. Reported here is a pediatric patient with a cochlear implant infection caused by methicillin-resistant Staphylococcus lugdunensis, a coagulase-negative Staphylococcus that has only recently been determined to be clinically relevant (1988). Unlike other coagulase-negative Staphylococcus, it is more aggressive, carrying a greater potential for tissue destruction. In pediatrics, the organism is uncommon, poorly described, and generally pan-susceptible. Described herein is the presentation and management of this unusual organism in a pediatric setting.
Insights
A pediatric cochlear implant infection was caused by methicillin-resistant Staphylococcus lugdunensis. This aggressive bacteria is uncommon in children and requires specific management strategies.
Area of Science:
- Otolaryngology
- Infectious Diseases
- Pediatric Medicine
Background:
- Cochlear implant infections commonly stem from Staphylococcus aureus or Pseudomonas aeruginosa.
- Methicillin-resistant Staphylococcus lugdunensis (MRSL) is a coagulase-negative Staphylococcus recognized for clinical relevance since 1988.
- MRSL is noted for its aggressive nature and potential for significant tissue destruction.
Observation:
- This report details a rare pediatric case of cochlear implant infection.
- The causative agent was identified as methicillin-resistant Staphylococcus lugdunensis (MRSL).
- MRSL is infrequently encountered in pediatric populations and is typically pan-susceptible.
Findings:
- The study presents the clinical presentation of MRSL in a pediatric cochlear implant recipient.
- Management strategies for this unusual infection in a pediatric patient are described.
- This case highlights the aggressive potential of MRSL even in generally susceptible strains.
Implications:
- Highlights the need for increased awareness of MRSL as a potential pathogen in pediatric cochlear implant infections.
- Informs clinical management approaches for MRSL infections in immunocompromised or device-dependent pediatric populations.
- Contributes to the limited literature on MRSL infections in children, emphasizing its clinical significance.
